Search research articles
Contact Us
Filters
Showing results (61-70 of 189) with videos related to
Page
of 19
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
July 17, 2004
Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells
David Masiello, Shao-Yong Chen, Youyuan Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 2, 2009
Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo
Simon C Yue, Michael Nowak, Angela Shaulov-Kask, et al.
Molecular Endocrinology (Baltimore, Md.)
|
January 5, 2002
AR and ER interaction with a p21-activated kinase (PAK6)
Suzanne R Lee, Sharon M Ramos, Andrew Ko, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 2, 2002
Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver
Mark A Exley, Qi He, Olivia Cheng, et al.
The Journal of Biological Chemistry
|
November 20, 2004
Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP kinase
Ramneet Kaur, Xia Liu, Ole Gjoerup, et al.
Cancers
|
January 11, 2022
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
Daniel Westaby, Juan M Jimenez-Vacas, Ana Padilha, et al.
Molecular Cancer Research : MCR
|
September 6, 2014
Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer
Adam G Sowalsky, Zheng Xia, Liguo Wang, et al.
Cancer Research
|
March 15, 2008
SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion
Hongyun Wang, Irwin Leav, Soichiro Ibaragi, et al.
Clinical Genitourinary Cancer
|
October 10, 2009
Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole alone
Oliver Sartor, Mari Nakabayashi, Mary-Ellen Taplin, et al.
Cancer Biology & Therapy
|
January 16, 2007
Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer
David Masiello, M Golam Mohi, Nicole C McKnight, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 189) with videos related to
Sort By:
Page
of 19
Molecular Endocrinology (Baltimore, Md.)
|
July 17, 2004
Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells
David Masiello, Shao-Yong Chen, Youyuan Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 2, 2009
Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo
Simon C Yue, Michael Nowak, Angela Shaulov-Kask, et al.
Molecular Endocrinology (Baltimore, Md.)
|
January 5, 2002
AR and ER interaction with a p21-activated kinase (PAK6)
Suzanne R Lee, Sharon M Ramos, Andrew Ko, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 2, 2002
Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver
Mark A Exley, Qi He, Olivia Cheng, et al.
The Journal of Biological Chemistry
|
November 20, 2004
Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP kinase
Ramneet Kaur, Xia Liu, Ole Gjoerup, et al.
Cancers
|
January 11, 2022
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
Daniel Westaby, Juan M Jimenez-Vacas, Ana Padilha, et al.
Molecular Cancer Research : MCR
|
September 6, 2014
Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer
Adam G Sowalsky, Zheng Xia, Liguo Wang, et al.
Cancer Research
|
March 15, 2008
SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion
Hongyun Wang, Irwin Leav, Soichiro Ibaragi, et al.
Clinical Genitourinary Cancer
|
October 10, 2009
Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole alone
Oliver Sartor, Mari Nakabayashi, Mary-Ellen Taplin, et al.
Cancer Biology & Therapy
|
January 16, 2007
Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer
David Masiello, M Golam Mohi, Nicole C McKnight, et al.
Page
of 19